Mannkind (MNKD) Receivables (2014 - 2026)
Mannkind (MNKD) reported Receivables of $28.1 million for Q1 2026, down 2.64% year-over-year from $28.9 million in Q1 2025, and down 26.66% on a QoQ basis from $38.4 million in Q4 2025.
Mannkind (MNKD) has 13 years of Receivables data on file, last reported at $28.1 million in Q1 2026.
- Quarterly Receivables fell 2.64% year-over-year to $28.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28.1 million (down 2.64% YoY) and the FY2025 annual result came in at $38.4 million, up 225.03% from the prior year.
- Receivables fell to $28.1 million in Q1 2026 per MNKD's latest filing, from $38.4 million in the prior quarter.
- Across five years, Receivables topped out at $38.4 million in Q4 2025 and bottomed at $900000.0 in Q1 2023.
- The 5-year median for Receivables is $19.9 million (2024), against an average of $20.3 million.
- The widest annual swing landed in 2023, when Receivables slumped 91.28%; it then surged 2112.44% in 2024.
- Tracing MNKD's Receivables over 5 years: stood at $16.8 million in 2022, then dropped by 11.31% to $14.9 million in 2023, then fell by 20.78% to $11.8 million in 2024, then jumped by 225.03% to $38.4 million in 2025, then declined by 26.66% to $28.1 million in 2026.
- Per Business Quant, the three latest MNKD Receivables figures stand at $28.1 million (Q1 2026), $38.4 million (Q4 2025), and $17.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 13.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 4.15 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2.00 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 5.73 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 883.96 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 28.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.14 Mn |
| Dec 31, 2025 | 38.37 Mn |
| Sep 30, 2025 | 17.38 Mn |
| Jun 30, 2025 | 27.14 Mn |
| Mar 31, 2025 | 28.90 Mn |
| Dec 31, 2024 | 11.80 Mn |
| Sep 30, 2024 | 18.18 Mn |
| Jun 30, 2024 | 23.35 Mn |
| Mar 31, 2024 | 19.91 Mn |
| Dec 31, 2023 | 14.90 Mn |
| Sep 30, 2023 | 22.22 Mn |
| Jun 30, 2023 | 27.99 Mn |
| Mar 31, 2023 | 900,000.00 |
| Dec 31, 2022 | 16.80 Mn |
| Sep 30, 2022 | 24.09 Mn |
| Jun 30, 2022 | 15.43 Mn |
| Mar 31, 2022 | 10.32 Mn |
| Dec 31, 2021 | 5.04 Mn |
| Sep 30, 2021 | 9.45 Mn |
| Jun 30, 2021 | 6.31 Mn |
| Mar 31, 2021 | 7.45 Mn |
| Dec 31, 2020 | 4.22 Mn |
| Sep 30, 2020 | 4.14 Mn |
| Jun 30, 2020 | 6.74 Mn |
| Mar 31, 2020 | 8.39 Mn |
| Dec 31, 2019 | 3.51 Mn |
| Sep 30, 2019 | 4.09 Mn |
| Jun 30, 2019 | 11.06 Mn |
| Mar 31, 2019 | 3.76 Mn |
| Dec 31, 2018 | 4.02 Mn |
| Sep 30, 2018 | 3.94 Mn |
| Jun 30, 2018 | 3.62 Mn |
| Mar 31, 2018 | 2.02 Mn |
| Dec 31, 2017 | 2.79 Mn |
| Sep 30, 2017 | 1.80 Mn |
| Jun 30, 2017 | 1.31 Mn |
| Mar 31, 2017 | 438,000.00 |
| Dec 31, 2016 | 30.56 Mn |
| Sep 30, 2016 | 3.14 Mn |
| Mar 31, 2016 | 144,000.00 |
| Dec 31, 2015 | 23,000.00 |
| Sep 30, 2015 | 1.68 Mn |
| Jun 30, 2015 | 4.75 Mn |
| Mar 31, 2015 | 4.28 Mn |
| Dec 31, 2014 | 50.44 Mn |